Email ID
Password
Scrip   
Biogen Idec raises offer for Facet by 21%
04 December 2009
Eleanor Malone

Biogen Idec has raised by 21% its offer for Facet Biotech, 13 days before its extended hostile tender offer was due to expire. Facet has advised its shareholders to take no action while its board of directors considers the revised offer; it plans to advise stockholders of its recommendation.
Biogen...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36